ArticleOncotarget2016

Correction: Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.

Francesca Pretto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.